Company Profile

Medipacs Inc (AKA: Medipacs Inc)
Profile last edited on: 10/12/22      CAGE: 473U0      UEI:

Business Identifier: Non-mechanical infusion pump based around a new expandable polymer
Year Founded
2004
First Award
2007
Latest Award
2008
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9040 South Rita Road Suite 2250
Tucson, AZ 85747
   (520) 382-3264
   info@medipacs.com
   www.medipacs.com
Location: Multiple
Congr. District: 02
County: 

Public Profile

With facilities also in San Diego, Medipacs, has achieved successful operation and pumping of the first fluids through the Medipacs polymer gel proof of concept device. The proprietary Digital Pump technology is being developed to drive or pump fluids for drug delivery and infusion therapies in the medical market. This first pump10 cell prototype is the precursor to medical applications of the new technology that Medipacs is currently developing. Able to operate on under 3 volts of power the new device has produced repeated results by pumping, very small, milligram amounts of water continuously over several hours and has attained pressures of over 3 psi. The pump has no mechanical parts and works by using polymer gels that expand and contract from the electrical current. The new device is controlled by a small computer chip that is programmed to pump the desired rates. Plans for the new Digital PumpT technology include a new medical infusion pump, around the size of a cell phone, that will provide a low cost alternative to expensive infusion pumps currently on the market. Eventually the pumps will be available in other devices such as a drug delivery patch and implantable devices that can monitor patient fluids and deliver medicine at the same time.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2008 2 NSF $650,000
Project Title: Dendritic Hydrogel Actuators for a Liquid Drug Delivery Patch

Key People / Management

  Mark McWilliams -- Chief Executive Officer

  Mark Banister -- Founder; Chief Technical Officer

  Anthony DeLizza -- Vice President, Marketing

  Laurie Hassey -- Director of Marketing

  David Loynd -- CFO

  Sonia Vohnout -- Systems Engineer

Company News